Skip to main content
Log in

Controlled comparison of the pharmacodynamic effects of nicorandil (SG-75) and isosorbide dinitrate in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Nicorandil (SG-75) is a long acting mononitrate. A randomized, double-blind, crossover study in 10 healthy subjects has compared the haemodynamic actions of single sublingual doses of nicorandil 15, 30 and 60 mg with Isosorbide dinitrate (ISDN) 5 mg and placebo. Heart rate, blood pressure, systolic time intervals (STI) and left ventricular echocardiograms were used to assess haemodynamics over a 6 h period. Within 15 min of nicorandil administration, heart rate increased and peripheral resistance decreased (dose-dependent); the preejection period (corrected; PEPc) and the ratio of PEP to left ventricular ejection time (LVET) — PEP/LVET — were shortened by the 60 mg dose; the heart rate corrected electromechanical systole (QS2c) was almost unchanged; left ventricular end diastolic and systolic diameters (EDD and ESD) were diminished. The effects on certain parameters had not completely disappeared after 6 h. ISDN produced a similar pattern with somewhat less intense effects; although PEPc and PEP/LVET were prolonged. The effects of both drugs can be attributed to vasodilatation on both the arteriolar and venous sides. The predominant action of ISDN was to reduce preload and thereby to lengthen PEPc and PEP/LVET; in addition, it lessened afterload. Although nicorandil caused a distinct reduction in preload, as shown by the smaller EDD, the effects of afterload reduction were predominant at the high dose induced shortening of PEPc and PEP/LVET. The profile of action of nicorandil should encourage clinical testing to evaluate its ability to induce ventricular unloading.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bayer O, Loogen F, Wolter HH (1967) Die Herzkatheterisierung bei angeborenen und erworbenen Herzfehlern, 2. Aufl. Thieme, Stuttgart, p 57

    Google Scholar 

  2. Belz GG, Aust PE, Belz G, Appel E, Palm D (1982) Sympathomimetic effects of amezinium on the cardiovascular system and plasma catecholamines in man. Eur J Clin Pharmacol 23: 15–20

    Google Scholar 

  3. Belz GG, Aust PE, Schneider B (1981) Time course of the effects of single intravenous doses of digitoxin and digoxin in normal volunteers. J Cardiovasc Pharmacol 3: 1116–1125

    Google Scholar 

  4. Buch J, Egeblad H, Hansen PB, Kjaergard H, Waldorff S, Steiness E (1980) Correlation between changes of systolic time intervals and left ventricular end-diastolic diameter after preload reduction. Non-invasive monitoring of pharmacological intervention. Br Heart J 44: 668–671

    Google Scholar 

  5. Chatterjee K, Parmley WW (1983) Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure. J Am Coll Cardiol 1: 133–153

    Google Scholar 

  6. De la Paz LR, Kerigan AT, Koch GG, Kolman WA, Spodick DH (1979) Erythrityl tetranitrate: Sustained effects on systolic time intervals. Changes consistent with sustained preload reduction. Am J Med Sci 277: 173–178

    Google Scholar 

  7. De Maria AN, Neumann A, Schubart PJ, Lee G, Mason DT (1979) Systemic correlation of cardiac chamber size and ventricular performance determined with echocardiography and alterations in heart rate in normal persons. Am J Cardiol 43: 1–9

    Google Scholar 

  8. Endoh M, Taira N (1983) Relationship between relaxation and cyclic GMP formation caused by Nicorandil in canine mesentheric artery. Naunyn-Schmiedeberg's Arch 322: 319–321

    Google Scholar 

  9. Erbel R, Belz GG (1977) Untersuchungen zur Meßmethode der systolischen Zeitintervalle. Z Kardiol 66: 433–435

    Google Scholar 

  10. Feigenbaum H (1981) Echocardiography, 3rd edn. Lea and Febiger, Philadelphia, pp 119–124

    Google Scholar 

  11. Holzmann S (1983) Cyclic GMP as possible mediator of coronary arterial relaxation by Nicorandil (SG 75). J Cardiovasc Pharmacol 5: 364–370

    Google Scholar 

  12. Kato K, Aizawa T, Ogasaware K, Fujii J (1983) Spasmolytic effects of nicorandil (SG-75), a new potent coronary dilator in variant angina pectoris. Fed Proc 42: 1174

    Google Scholar 

  13. Sakai K, Shiraki Y, Nabata H (1981) Cardiovascular effect of a new coronary vasodilator, 2-nicotinamide ethyl nitrate (SG75): comparison with nitroglycerin and diltiazem. J Cardiovasc Pharmacol 3: 139–150

    Google Scholar 

  14. Thormann J, Schlepper M, Kramer W, Gottwick M (1982) Wirkungsnachweis von Nicorandil (SG-75), einer Substanz mit Nitroeigenschaften und Langzeitwirkung bei Koronarkranken: Verbesserung von LV-Funktion und regionaler Wandbeweglichkeit unter Ausbleiben pacing-induzierter Myocardischaemie. Z Kardiol 71: 747–753

    Google Scholar 

  15. Weissler AM, Harris WS, Schoenfeld CD (1968) Systolic time intervals in heart failure in man. Circulation 37: 149–159

    Google Scholar 

  16. Weissler AM, Schoenfeld CD (1970) Effect of digitalis on systolic time intervals in heart failure. Am J Med Sci 259: 4–20

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Belz, G.G., Matthews, J., Heinrich, J. et al. Controlled comparison of the pharmacodynamic effects of nicorandil (SG-75) and isosorbide dinitrate in man. Eur J Clin Pharmacol 26, 681–685 (1984). https://doi.org/10.1007/BF00541925

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00541925

Key words

Navigation